Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin adjunct to non-surgical periodontal therapy for severe grade C periodontitis
ACTRN12619000560190Phase 3Completed
- Sponsor
- The University of Queensland
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of azithromycin in periodontitis, sponsored by The University of Queensland. Primary endpoint: Mean change in overall periodontal inflamed surface area score at 12 months. Started Apr 2019; status: completed.
02
Drugs
azithromycin
03
Conditions
periodontitis
Beyond the preview
Go deeper on ACTRN12619000560190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000560190.